Rapid and durable responses with the SYK/JAK inhibitor cerdulatinib in a phase 2 study in relapsed/refractory follicular lymphoma - alone or in combination with rituximab Meeting Abstract
| Authors: | Smith, S. D.; Munoz, J.; Stevens, D. A.; Smith, S. M.; Feldman, T. A.; Ye, J. C.; de Vos, S.; Hess, B. T.; Miller, C. B.; Khatcheressian, J. L.; Birrell, M. R.; Leeds, J. M.; Coffey, G. P.; Conley, P. B.; Michelson, G. C.; Curnutte, J. T.; Hamlin, P. A. |
| Abstract Title: | Rapid and durable responses with the SYK/JAK inhibitor cerdulatinib in a phase 2 study in relapsed/refractory follicular lymphoma - alone or in combination with rituximab |
| Meeting Title: | 15th International Conference on Malignant Lymphoma |
| Journal Title: | Hematological Oncology |
| Volume: | 37 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2019 Jun 18-22 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2019-06-01 |
| Start Page: | 61 |
| End Page: | 62 |
| Language: | English |
| ACCESSION: | 136932688 |
| DOI: | 10.1002/hon.30_2629 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| PUBMED: | 31187525 |
| DOI/URL: | |
| Notes: | Meeting abstract: 030 -- Accession Number: 136932688 -- Entry Date: In Process -- Revision Date: 20190617 -- Publication Type: Article -- Supplement Title: Jun2019 Supplement S1 -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20 |
